554
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Development and Psychometric Testing of a New Short-Form of the Premenstrual Symptoms Questionnaire (PSQ-S)

ORCID Icon, , &
Pages 899-911 | Published online: 14 Jul 2022

References

  • Yonkers KA, Simoni MK. Premenstrual disorders. Am J Obstet Gynecol. 2018;218(1):68–74. doi:10.1016/j.ajog.2017.05.045
  • Green LJ, O’Brien PM, Panay N, Craig M. Management of premenstrual syndrome: green-top guideline no. 48. BJOG. 2017;124(3):e73–e105. doi:10.1111/1471-0528.14260
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington (VA): American Psychiatric Association; 2013.
  • O’Brien PM, Backstrom T, Brown C, et al. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health. 2011;14(1):13–21. doi:10.1007/s00737-010-0201-3
  • Borenstein JE, Dean BB, Leifke E, Korner P, Yonkers KA. Differences in symptom scores and health outcomes in premenstrual syndrome. J Womens Health. 2007;16(8):1139–1144. doi:10.1089/jwh.2006.0230
  • Qiao M, Zhang H, Liu H, et al. Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in a population-based sample in China. Eur J Obstet Gynecol Reprod Biol. 2012;162(1):83–86. doi:10.1016/j.ejogrb.2012.01.017
  • Cohen LS, Soares CN, Otto MW, Sweeney BH, Liberman RF, Harlow BL. Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women: the Harvard study of moods and cycles. J Affect Disorders. 2002;70(2):125–132. doi:10.1016/S0165-0327(01)00458-X
  • Gehlert S, Song I, Chang C-H, Hartlage S. The prevalence of premenstrual dysphoric disorder in a randomly selected group of urban and rural women. Psychol Med. 2009;39(1):129–136. doi:10.1017/S003329170800322X
  • Hantsoo L, Epperson CN. Allopregnanolone in premenstrual dysphoric disorder (PMDD): evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle. Neurobiol Stress. 2020;12:100213. doi:10.1016/j.ynstr.2020.100213
  • Grady-Weliky TA. Clinical practice. Premenstrual dysphoric disorder. N Engl J Med. 2003;348(5):433–438. doi:10.1056/NEJMcp012067
  • Bixo M, Ekberg K, Poromaa IS, et al. Treatment of premenstrual dysphoric disorder with the GABA (A) receptor modulating steroid antagonist sepranolone (UC1010)-A randomized controlled trial. Psychoneuroendocrinology. 2017;80:46–55. doi:10.1016/j.psyneuen.2017.02.031
  • Yoshimi K, Shiina M, Takeda T. Lifestyle factors associated with premenstrual syndrome: a cross-sectional study of Japanese high school students. J Pediatr Adolesc Gynecol. 2019;32(6):590–595. doi:10.1016/j.jpag.2019.09.001
  • Mortola JF, Girton L, Beck L, Yen SS. Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: the calendar of premenstrual experiences. Obstet Gynecol. 1990;76(2):302–307.
  • Endicott J, Nee J, Harrison W. Daily record of severity of problems (DRSP): reliability and validity. Arch Womens Ment Health. 2006;9(1):41–49. doi:10.1007/s00737-005-0103-y
  • Takeda T, Kai S, Yoshimi K. Psychometric testing of the Japanese version of the daily record of severity of problems among Japanese women. Int J Womens Health. 2021;13:361–367. doi:10.2147/IJWH.S301260
  • Takeda T, Chiba Y. Evaluation of a natural S-equol supplement in treating premenstrual symptoms and the effect of the gut microbiota: an open-label pilot study. Neuropsychopharmacol Rep. 2022;42:127–134. doi:10.1002/npr2.12234
  • Steiner M, Macdougall M, Brown E. The premenstrual symptoms screening tool (PSST) for clinicians. Arch Womens Ment Health. 2003;6(3):203–209. doi:10.1007/s00737-003-0018-4
  • Hariri FZ, Moghaddam-Banaem L, Siah Bazi S, Saki Malehi A, Montazeri A. The Iranian version of the premenstrual symptoms screening tool (PSST): a validation study. Arch Womens Ment Health. 2013;16(6):531–537. doi:10.1007/s00737-013-0375-6
  • Pacitti F, Iorio C, Riccobono G, Iannitelli A, Pompili A. Assessment of premenstrual symptoms: validation of the Italian version of the premenstrual symptoms screening Tool. Riv Psichiatr. 2021;56(5):246–253. doi:10.1708/3681.36672
  • Mahfoud Z, Emam R, Anchassi D, et al. Premenstrual dysphoric disorder in Arab women: validation and cultural adaptation of the Arabic version of the premenstrual screening tool. Women Health. 2019;59(6):631–645. doi:10.1080/03630242.2018.1539433
  • Miyaoka Y, Akimoto Y, Ueda K, et al. Fulfillment of the premenstrual dysphoric disorder criteria confirmed using a self-rating questionnaire among Japanese women with depressive disorders. Biopsychosoc Med. 2011;5:5. doi:10.1186/1751-0759-5-5
  • Takeda T, Tasaka K, Sakata M, Murata Y. Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in Japanese women. Arch Womens Ment Health. 2006;9(4):209–212. doi:10.1007/s00737-006-0137-9
  • Takeda T, Koga S, Yaegashi N. Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in Japanese high school students. Arch Womens Ment Health. 2010;13(6):535–537. doi:10.1007/s00737-010-0181-3
  • Takeda T, Yoshimi K, Yamada K. Psychometric testing of the premenstrual symptoms questionnaire and the association between perceived injustice and premenstrual symptoms: a cross-sectional study among Japanese high school students. Int J Womens Health. 2020;12:755–763. doi:10.2147/IJWH.S269392
  • Ware JJE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–483. doi:10.1097/00005650-199206000-00002
  • Ware JJE, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–233. doi:10.1097/00005650-199603000-00003
  • Jabrayilov R, Emons WHM, Sijtsma K. Comparison of classical test theory and item response theory in individual change assessment. Appl Psychol Meas. 2016;40(8):559–572. doi:10.1177/0146621616664046
  • Matsudaira K, Oka H, Kawaguchi M, et al. Development of a Japanese version of the somatic symptom scale-8: psychometric validity and internal consistency. Gen Hosp Psychiatry. 2017;45:7–11. doi:10.1016/j.genhosppsych.2016.12.002
  • Marsh HW, Hocevar D. Application of confirmatory factor analysis to the study of self-concept: first- and higher order factor models and their invariance across groups. Psychol Bull. 1985;97(3):562–582. doi:10.1037/0033-2909.97.3.562
  • Hooper DCJ, Mullen MR. Structural equation modelling: guidelines for determining model fit. Electron J Bus Res Methods. 2008;6(1):53–60.
  • Hu L-T, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Model. 1999;6(1):1–55. doi:10.1080/10705519909540118
  • Samejima F. Estimation of latent ability using a response pattern of graded scores. Psychometrika Monogr Suppl. 1969;34:100.
  • Baker FB. The Basics of Item Response Theory. 2nd ed. Washington (DC): ERIC; 2001.
  • Toland MD. Practical guide to conducting an item response theory analysis. J Early Adolesc. 2014;34(1):120–151. doi:10.1177/0272431613511332
  • Youngstrom EA. A primer on receiver operating characteristic analysis and diagnostic efficiency statistics for pediatric psychology: we are ready to ROC. J Pediatr Psychol. 2014;39(2):204–221. doi:10.1093/jpepsy/jst062
  • Kumagai R. Development of IRT analysis programs for beginners: easyEstimation series. Jpn J Res Test. 2009;5(1):107–118.
  • Neal DJ, Corbin WR, Fromme K. Measurement of alcohol-related consequences among high school and college students: application of item response models to the rutgers alcohol problem index. Psychol Assess. 2006;18(4):402–414. doi:10.1037/1040-3590.18.4.402
  • Sliwerski A, Koszalkowska K. The influence of depression on biased diagnosis of premenstrual syndrome and premenstrual dysphoric disorder by the PSST inventory. Life. 2021;11:1278. doi:10.3390/life11111278
  • Yoshimi K, Matsumura N, Takeda T. When and how do adolescent girls in Japan become aware of premenstrual symptoms from menarche? A cross-sectional study among senior high school students. BMJ Open. 2021;11(8):e045215–e045215. doi:10.1136/bmjopen-2020-045215
  • Steiner M, Peer M, Palova E, Freeman EW, Macdougall M, Soares CN. The premenstrual symptoms screening tool revised for adolescents (PSST-A): prevalence of severe PMS and premenstrual dysphoric disorder in adolescents. Arch Womens Ment Health. 2011;14(1):77–81. doi:10.1007/s00737-010-0202-2
  • Kitamura M, Takeda T, Koga S, Nagase S, Yaegashi N. Relationship between premenstrual symptoms and dysmenorrhea in Japanese high school students. Arch Womens Ment Health. 2012;15(2):131–133. doi:10.1007/s00737-012-0266-2